常用特应性皮炎严重度评估方法

doi:10.35541/cjd.20200825

Abstract

Yao Xu. How to evaluate the severity of atopic dermatitis? [J]. Chinese Journal of Dermatology, 2021, 54(6): 539-541.doi:10.35541/cjd.20200825

References ［18］

［1］	Hill MK, Kheirandish Pishkenari A, Braunberger TL, et al. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: a systematic review［J］. J Am Acad Dermatol, 2016,75（5）:906⁃917. doi: 10.1016/j.jaad.2016. 07.002.
［2］	Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis［J］. Dermatology, 1993,186（1）:23⁃31. doi: 10.1159/000247298.
［3］	Tofte S. Eczema area and severity index （EASI）: a new tool to evaluate atopic dermatitis［J］. J Eur Acad Dermatol Venereol, 1998,11（Suppl 2）:S197. doi: 10.1016/S0926⁃9959（98）95291⁃6.
［4］	Rehal B, Armstrong AW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality⁃of⁃life instruments 1985⁃2010［J/OL］. PLoS One, 2011,6（4）:e17520. doi: 10.1371/journal.pone.0017520.
［5］	Spuls PI, Gerbens L, Simpson E, et al. Patient⁃oriented eczema measure （POEM）, a core instrument to measure symptoms in clinical trials: a harmonising outcome measures for eczema （HOME） statement［J］. Br J Dermatol, 2017,176（4）:979⁃984. doi: 10.1111/bjd.15179.
［6］	Pariser DM, Simpson EL, Gadkari A, et al. Evaluating patient⁃perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool （ADCT）［J］. Curr Med Res Opin, 2020,36（3）:367⁃376. doi: 10.1080/03007995. 2019.1699516.
［7］	Yosipovitch G, Reaney M, Mastey V, et al. Peak pruritus numerical rating scale: psychometric validation and responder definition for assessing itch in moderate⁃to⁃severe atopic dermatitis［J］. Br J Dermatol, 2019,181（4）:761⁃769. doi: 10. 1111/bjd.17744.
［8］	Finlay AY, Khan GK. Dermatology life quality index （DLQI）⁃a simple practical measure for routine clinical use［J］. Clin Exp Dermatol, 1994,19（3）:210⁃216. doi: 10.1111/j.1365⁃2230.1994.tb01167.x.
［9］	Lewis⁃Jones MS, Finlay AY. The Children′s Dermatology Life Quality Index （CDLQI）: initial validation and practical use［J］. Br J Dermatol, 1995,132（6）:942⁃949. doi: 10.1111/j.1365⁃2133. 1995.tb16953.x.
［10］	Zigmond AS, Snaith RP. The hospital anxiety and depression scale［J］. Acta Psychiatr Scand, 1983,67（6）:361⁃370.
［11］	Rabin R, de Charro F. EQ⁃5D: a measure of health status from the EuroQol Group［J］. Ann Med, 2001,33（5）:337⁃343. doi: 10. 3109/07853890109002087.
［12］	Simpson E, Eckert L, Gadkari A, et al. Validation of the Atopic Dermatitis Control Tool （ADCT©） using a longitudinal survey of biologic⁃treated patients with atopic dermatitis［J］. BMC Dermatol, 2019,19（1）:15. doi: 10.1186/s12895⁃019⁃0095⁃3.
［13］	Thomas KS, Apfelbacher CA, Chalmers JR, et al. Recommended core outcome instruments for health⁃related quality of life, long⁃term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting［J］. Br J Dermatol, 2020. doi: 10.1111/bjd.19673.
［14］	Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate to severe atopic dermatitis （AD）: insights from a phase 2b clinical trial of dupilumab in adults［J］. J Am Acad Dermatol, 2016,74（3）:491⁃498. doi: 10.1016/j.jaad.2015.10.043.
［15］	Sandhu JK, Wu KK, Bui TL, et al. Association between atopic dermatitis and suicidality: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2019,155（2）:178⁃187. doi: 10. 1001/jamadermatol.2018.4566.
［16］	Thijs J, Krastev T, Weidinger S, et al. Biomarkers for atopic dermatitis: a systematic review and meta⁃analysis［J］. Curr Opin Allergy Clin Immunol, 2015,15（5）:453⁃460. doi: 10.1097/ACI. 0000000000000198.
［17］	Himadri, George R, Mathew L, et al. The role of thymus and activation⁃regulated chemokine as a marker of severity of atopic dermatitis［J］. J Am Acad Dermatol, 2021,84（2）:545⁃547. doi: 10.1016/j.jaad.2020.05.052.
［18］	Gu CY, Gu L, Dou X. Serum levels of thymus and activation⁃regulated chemokine can be used in the clinical evaluation of atopic dermatitis［J］. Int J Dermatol, 2015,54（7）:e261⁃e265. doi: 10.1111/ijd.12830.

[1]	Fu Chao, Wu Jiaona, Lang Wenchao, Gao Fei, Niu Guiye, Bian Peiwen, Gao Minhong, Si Xiaoqing, Xin Linlin. Role of dermoscopy in assessing vitiligo activity [J]. Chinese Journal of Dermatology, 2022, 55(3): 268-271.
[2]	Huang Yaxin, He Yuanmin, Huang Shuli, Xiong Xia, Deng Yongqiong. An investigation into clinical significance of serum chitinase 3-like protein 1 in pemphigus vulgaris [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210155-e20210155.
[3]	Ma Xiao, Li Chengrang, Wang Baoxi, He Yanyan, Xu Haoxiang. Severity assessment criteria for acne inversa/hidradenitis suppurativa [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210236-e20210236.
[4]	Li Jinyi, Zhang Ting, Liu Lidan, Chen Yongfeng . Expression of Sprouty1, 2 and 4 in skin lesions of patients with psoriasis vulgaris and its significance [J]. Chinese Journal of Dermatology, 2020, 53(8): 629-633.
[5]	Chen Yudi, Liu Bo, Song Xiaoting, Zhao Zuotao. Clinical application of critical temperature threshold measurement in cold contact urticaria [J]. Chinese Journal of Dermatology, 2020, 53(5): 352-355.
[6]	Zhou Yuan, Chen Wei, Wang Daguang. Treatment of pincer nails [J]. Chinese Journal of Dermatology, 2019, 52(5): 364-367.
[7]	Wu Wenhai, Yi Fan, Meng Hong . Evaluation methods for sensitive skin [J]. Chinese Journal of Dermatology, 2019, 52(4): 275-278.
[8]	Wu Yuanyuan, Zheng Jie, Xiao Fengli. Analysis of factors influencing disease severity in 2 620 children with atopic dermatitis [J]. Chinese Journal of Dermatology, 2019, 52(12): 915-919.
[9]	Ming LI jianmin chang. Clinical scoring systems of vitiligo [J]. Chinese Journal of Dermatology, 2018, 51(6): 478-479.
[10]	Wu Huimei, Yao Danni, Guo Jie, Lu Chuanjian. Measurement of psoriasis-involved body surface area based on a standard operating procedure for evaluating psoriasis severity: a multicenter clinical study on consistency [J]. Chinese Journal of Dermatology, 2018, 51(10): 745-748.
[11]	. Relationship between the serum level of transglutaminase 2?specific IgE and disease condition in patients with atopic dermatitis [J]. Chinese Journal of Dermatology, 2017, 50(7): 508-511.
[12]	Mengya /Chen Jie ZHENG Hua Cao. Clinical application of scoring systems of dermatomyositis [J]. Chinese Journal of Dermatology, 2017, 50(1): 70-72.
[13]	. Detection of serum levels of 25-hydroxy vitamin D in patients with chronic urticaria and its clinical significance [J]. Chinese Journal of Dermatology, 2016, 49(9): 653-655.
[14]	. Detection of vitamin D in sera of patients with atopic dermatitis and its clinical significance [J]. Chinese Journal of Dermatology, 2016, 49(9): 612-615.
[15]	. MicroRNA profiles in peripheral blood and skin lesions of patients with psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2016, 49(11): 789-792.

How to evaluate the severity of atopic dermatitis?

PDF

Knowledge

Abstract

Cite this article

share this article

References ［18］

Related Articles 15

Metrics

Comments

Recommended 10